WPDPF Stock Price, Chart, Stats & News

WPD Pharmaceuticals Inc., with its main office located in Vancouver, Canada, specializes in the discovery and development of pharmaceutical agents. The company's core mission is to advance innovative treatments for both various forms of cancer (oncology) and infectious diseases. Their active development pipeline showcases a diverse array of drug candidates: Preclinical evaluation is currently underway for WPD101, designed to combat brain cancers, including glioblastoma; WPD102, targeting Uveal Melanoma; and WPD103, which is aimed at glioblastoma multiforme.